BRPI0809902A2 - Métodos de avaliar células e culturas celulares - Google Patents

Métodos de avaliar células e culturas celulares

Info

Publication number
BRPI0809902A2
BRPI0809902A2 BRPI0809902-2A2A BRPI0809902A BRPI0809902A2 BR PI0809902 A2 BRPI0809902 A2 BR PI0809902A2 BR PI0809902 A BRPI0809902 A BR PI0809902A BR PI0809902 A2 BRPI0809902 A2 BR PI0809902A2
Authority
BR
Brazil
Prior art keywords
methods
assessing cells
crops
cell
cell crops
Prior art date
Application number
BRPI0809902-2A2A
Other languages
English (en)
Inventor
Stephen M Rapko
Stephen J Duguay
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of BRPI0809902A2 publication Critical patent/BRPI0809902A2/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6851Quantitative amplification
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4722Proteoglycans, e.g. aggreccan
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
    • G01N2400/40Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BRPI0809902-2A2A 2007-04-06 2008-04-03 Métodos de avaliar células e culturas celulares BRPI0809902A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91057407P 2007-04-06 2007-04-06
PCT/US2008/059275 WO2008124508A1 (en) 2007-04-06 2008-04-03 Methods of evaluating cells and cell cultures

Publications (1)

Publication Number Publication Date
BRPI0809902A2 true BRPI0809902A2 (pt) 2014-10-07

Family

ID=39629001

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0809902-2A2A BRPI0809902A2 (pt) 2007-04-06 2008-04-03 Métodos de avaliar células e culturas celulares

Country Status (20)

Country Link
US (3) US8029992B2 (pt)
EP (2) EP2442104A3 (pt)
JP (2) JP5383654B2 (pt)
KR (1) KR20090127153A (pt)
CN (1) CN101680881B (pt)
AR (1) AR066403A1 (pt)
AT (1) ATE541211T1 (pt)
AU (1) AU2008237332A1 (pt)
BR (1) BRPI0809902A2 (pt)
CA (1) CA2682948C (pt)
DK (1) DK2132562T3 (pt)
ES (1) ES2380753T3 (pt)
HR (1) HRP20120299T1 (pt)
IL (1) IL201225A0 (pt)
MX (1) MX2009010694A (pt)
MY (1) MY153234A (pt)
PL (1) PL2132562T3 (pt)
PT (1) PT2132562E (pt)
SI (1) SI2132562T1 (pt)
WO (1) WO2008124508A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006007560A2 (en) 2004-07-01 2006-01-19 University Of Pennsylvania Targeted protein replacement for the treatment of lysosomal storage disorders
US8921109B2 (en) 2005-09-19 2014-12-30 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
JP5557084B2 (ja) * 2009-03-17 2014-07-23 独立行政法人物質・材料研究機構 組織再生方法
WO2011011593A1 (en) * 2009-07-23 2011-01-27 Aderans Research Institute, Inc. Identity markers
JP2013527834A (ja) * 2010-03-29 2013-07-04 マサチューセッツ インスティテュート オブ テクノロジー 抗炎症因子
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
EP2642292A4 (en) * 2010-11-16 2014-05-14 Mitsubishi Chem Corp TEST PROCEDURE FOR BRAIN STICKS BY MEANS OF ACIDIC ACID PROTEIN 1
KR101316702B1 (ko) * 2011-04-20 2013-10-10 서울대학교산학협력단 곤충의 표지 유전자를 이용한, 곤충의 맥주 유입 시기 계산 방법
US8834928B1 (en) 2011-05-16 2014-09-16 Musculoskeletal Transplant Foundation Tissue-derived tissugenic implants, and methods of fabricating and using same
SI2753346T1 (sl) 2011-09-07 2020-09-30 Mount Sinai School Of Medicine Ceramidaza in diferenciacija celic
HUE051020T2 (hu) 2012-06-01 2021-01-28 Icahn School Med Mount Sinai A ceramid szintjei a fertõzések kezelésében és megelõzésében
WO2014160390A1 (en) 2013-03-14 2014-10-02 Icahn School Of Medicine At Mount Sinai Therapeutic acid ceramidase compositions and methods of making and using them
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
EP3297694A1 (en) 2015-05-21 2018-03-28 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers
DE102016213684A1 (de) 2016-07-26 2018-02-01 Tetec Tissue Engineering Technologies Ag Marker und Verfahren zur Beurteilung der Zusammensetzung oder Reinheit einer Zellkultur sowie zur in vitro Bestimmung der Identität einer Knorpelzelle oder einer Synovialzelle
WO2018164290A1 (ko) * 2017-03-06 2018-09-13 중앙대학교 산학협력단 Hapln1을 이용한 피부 노화 측정 또는 예방 또는 개선용 조성물
EP3417888A1 (de) * 2017-06-25 2018-12-26 co.don AG Verfahren zum herstellen von transplantierbarem knorpelgewebe
CN112048563B (zh) * 2020-09-09 2022-12-02 福建华民生物科技有限公司 一种利用软骨特异性基因表达程度控制软骨质量的方法
JP7222001B2 (ja) * 2021-01-22 2023-02-14 ハプルサイエンス・インコーポレイテッド Hapln1を利用した皮膚老化の測定用または予防用または改善用の組成物
CN119235920B (zh) * 2024-12-06 2025-06-24 浙江大学 一种用于关节软骨损伤修复的mfap5阳性滑膜衬里层干细胞及其鉴定方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998004681A2 (en) 1996-07-25 1998-02-05 Genzyme Corporation Chondrocyte media formulations and culture procedures
EP0956364A1 (en) * 1996-07-26 1999-11-17 Genzyme Corporation Whole cell assay
US20030087259A1 (en) * 2001-04-18 2003-05-08 Clancy Brian M. Methods and compositions for regulating bone and cartilage formation
WO2003064598A2 (en) 2002-01-25 2003-08-07 Genzyme Corporation Serum-free media for chondrocytes and methods of use thereof
EP1863924A2 (en) * 2005-03-11 2007-12-12 Epiontis GmbH Specific dnas for epigenetic characterisation of cells and tissues
US9234897B2 (en) * 2005-03-31 2016-01-12 Two Cells Co., Ltd Method for distinguishing mesenchymal stem cell using molecular marker and use thereof
WO2007058671A1 (en) * 2005-11-21 2007-05-24 West Michael D Novel uses of cells with prenatal patterns of gene expression
AU2007261530B2 (en) 2006-06-20 2014-02-06 Genzyme Corporation Serum-free media and their uses for chondrocyte expansion

Also Published As

Publication number Publication date
CA2682948C (en) 2016-05-31
CN101680881A (zh) 2010-03-24
JP2014036658A (ja) 2014-02-27
ES2380753T9 (es) 2012-11-27
KR20090127153A (ko) 2009-12-09
US20080248481A1 (en) 2008-10-09
ATE541211T1 (de) 2012-01-15
MX2009010694A (es) 2009-10-22
SI2132562T1 (sl) 2012-05-31
US20120149013A1 (en) 2012-06-14
US20120329051A1 (en) 2012-12-27
DK2132562T3 (da) 2012-04-30
HK1138374A1 (en) 2010-08-20
AU2008237332A1 (en) 2008-10-16
HRP20120299T1 (hr) 2012-04-30
US8029992B2 (en) 2011-10-04
EP2132562B1 (en) 2012-01-11
PT2132562E (pt) 2012-04-19
PL2132562T3 (pl) 2012-06-29
AR066403A1 (es) 2009-08-19
EP2442104A2 (en) 2012-04-18
EP2132562B9 (en) 2012-05-23
EP2132562A1 (en) 2009-12-16
EP2442104A3 (en) 2012-04-25
JP2010523124A (ja) 2010-07-15
IL201225A0 (en) 2010-05-31
JP5383654B2 (ja) 2014-01-08
CA2682948A1 (en) 2008-10-16
MY153234A (en) 2015-01-29
WO2008124508A1 (en) 2008-10-16
ES2380753T3 (es) 2012-05-18
CN101680881B (zh) 2013-04-24

Similar Documents

Publication Publication Date Title
BRPI0809902A2 (pt) Métodos de avaliar células e culturas celulares
BRPI0821042A2 (pt) Célula de lítio
EP2109913A4 (en) ELECTROCHEMICAL CELL SYSTEM
PL2634242T3 (pl) Ulepszony sposób hodowli komórek
BRPI0915146A2 (pt) programação e reprodução de células
BR112012014158A2 (pt) "célula eletroquímica"
BRPI0912297A2 (pt) células primárias de lítio
BRPI0821262A2 (pt) Célula fotovoltaica e dispositivo fotovoltaico
DK2344682T3 (da) Elektrode for elektrolysecelle
DE112006004268A5 (de) Elektrochemische Zelle
DE602007004421D1 (de) Zellkulturvorrichtung
DK3495498T3 (da) Genekspressionsanalyse i enkeltceller
DK2185693T3 (da) Differentiering af humane embryoniske stamceller
DE602008001332D1 (de) Batterieelektrode
DE602008001226D1 (de) Lithiumbatterie
BRPI0907433A2 (pt) Célula de litio
FR2928157B1 (fr) Module de cellule habitable et cellule habitable correspondante
EP2211411A4 (en) Fuel cell system
DK2313956T3 (da) Forbedringer til og vedrørende batteristyring
EP2128242A4 (en) CELL CULTURE MODULE
BRPI0816921A2 (pt) Cátodo de célula de lítio
DE112007001371B8 (de) Brennstoffzelle
BRPI0907886A2 (pt) Célula de lítio
DK2027150T3 (da) Allo-begrænsede peptid-specifikke t-celler
BRPI0814572A2 (pt) Célula de lítio

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]